Orbimed Advisors LLC Oric Pharmaceuticals, Inc. Transaction History

Orbimed Advisors LLC

$2.93 Billion
Q3 2025

A detailed history of Orbimed Advisors LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 3,641,756 shares of ORIC stock, worth $47.7 Million. This represents 1.48% of its overall portfolio holdings.

Number of Shares

3,641,756

Previous 899,281 304.96%

Holding current value

$47.7 Million

Previous $9.13 Million 376.02%

% of portfolio

1.48%

Previous 0.33%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$9.2 - $11.93 $25.2 Million - $32.7 Million	2,742,475 Added 304.96%	3,641,756 $43.4 Million
Q2 2025 Aug 14, 2025	BUY	$4.26 - $10.55 $848,937 - $2.1 Million	199,281 Added 28.47%	899,281 $9.13 Million
Q1 2025 May 15, 2025	BUY	$5.58 - $12.54 $3.91 Million - $8.78 Million	700,000 New	700,000 $3.91 Million
Q1 2024 May 15, 2024	SELL	$8.04 - $16.03 $1.9 Million - $3.78 Million	-235,868 Reduced 45.1%	287,100 $3.95 Million
Q4 2023 Feb 14, 2024	SELL	$5.41 - $9.43 $2.01 Million - $3.5 Million	-370,700 Reduced 41.48%	522,968 $4.81 Million
Q3 2023 Nov 14, 2023	SELL	$6.05 - $9.28 $1.66 Million - $2.55 Million	-274,800 Reduced 23.52%	893,668 $5.41 Million
Q2 2023 Aug 14, 2023	SELL	$4.95 - $8.4 $1.02 Million - $1.73 Million	-206,000 Reduced 14.99%	1,168,468 $9.07 Million
Q1 2023 May 15, 2023	SELL	$4.26 - $6.75 $993,006 - $1.57 Million	-233,100 Reduced 14.5%	1,374,468 $7.83 Million
Q4 2022 Feb 14, 2023	SELL	$2.41 - $5.89 $1.16 Million - $2.83 Million	-480,000 Reduced 22.99%	1,607,568 $9.47 Million
Q1 2022 May 16, 2022	SELL	$4.54 - $16.1 $1.14 Million - $4.03 Million	-250,006 Reduced 10.7%	2,087,568 $11.1 Million
Q1 2021 May 17, 2021	SELL	$23.67 - $36.85 $13.8 Million - $21.5 Million	-584,393 Reduced 20.0%	2,337,574 $57.3 Million
Q2 2020 Aug 14, 2020	BUY	$25.68 - $38.12 $75 Million - $111 Million	2,921,967 New	2,921,967 $98.6 Million

Others Institutions Holding ORIC

# of Institutions

157

Shares Held

105M

Call Options Held

35.1K

Put Options Held

173K

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $518M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account

Orbimed Advisors LLC Oric Pharmaceuticals, Inc. Transaction History